Magnoflorine improves sensitivity to doxorubicin (DOX) of breast cancer cells via inducing apoptosis and autophagy through AKT/mTOR and p38 signaling pathways
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference47 articles.
1. The biological age linked to oxidative stress modifies breast cancer aggressiveness;del Mar Sáez-Freire;Free Radic. Biol. Med.,2018
2. High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: implications for cancer stem cell resistance;Ryoo;Redox Biol.,2018
3. Pembrolizumab in patients with advanced triple-negative breast cancer: phase Ib KEYNOTE-012 study;Nanda;J. Clin. Oncol.,2016
4. Cellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factors;Peiris;Sci. Rep.,2017
5. Enzyme-responsive release of doxorubicin from monodisperse dipeptide‐based nanocarriers for highly efficient cancer treatment in vitro;Zhang;Adv. Funct. Mater.,2015
Cited by 102 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ferroptosis-inducing nanomedicine and targeted short peptide for synergistic treatment of hepatocellular carcinoma;Journal of Nanobiotechnology;2024-09-03
2. Carboxylated mesoporous silica nanoparticle-nucleic acid chimera conjugate-assisted delivery of siRNA and doxorubicin effectively treat drug-resistant bladder cancer.;Biomedicine & Pharmacotherapy;2024-09
3. Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors;Journal of Natural Products;2024-08-13
4. Emamectin benzoate-induced toxicity affects intestinal epithelial integrity involving apoptosis;Food and Chemical Toxicology;2024-08
5. Tanshinone I improves TNBC chemosensitivity by suppressing late-phase autophagy through AKT/p38 MAPK signaling pathway;Biomedicine & Pharmacotherapy;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3